Delivery Order SPE2DB22D2206-SPE2DB25FKA69
Award Date 9/22/25
Potential Completion Date 10/14/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,119.36 firm fixed price delivery order to AmerisourceBergen Drug Corp for INQOVI 35 mg–100 mg tablets (5 units) on August 22, 2025, with completion targeted for September 15, 2025. This non-set-aside award represents a child order under AmerisourceBergen's broader indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $5,119.36 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for INQOVI 35 mg-100 mg tablets (5-count units), with performance expected in Conshohocken, Pennsylvania by September 10, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The IDC serves...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 23, 2025, valued at $10,238.74 for INQOVI 35 MG-100 MG tablets (55 units) through the Defense Logistics Agency. The contract is a firm fixed price delivery order with an ultimate completion date of October 15, 2025, and represents a competitively awarded, non-set-aside procurement. This delivery order is issued under AmerisourceBergen's larger...
- This delivery order, issued by the Defense Logistics Agency (DLA) on July 23, 2025, awards AmerisourceBergen Drug Corp $5,119.36 for the supply of INQOVI 35 mg-100 mg tablets in quantities of 5 units. The contract, which is non-set-aside and competitively awarded, represents a firm fixed-price delivery order with a completion date of August 13, 2025, and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,997.42, is for the delivery of the drug Inqovi 35 mg-100 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of January 21, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $40,959.52 to AmerisourceBergen Drug Corp on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. AmerisourceBergen Drug...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,586.87 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $76,278.37 to AmerisourceBergen Drug Corp on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order, issued under a competitive process with no set-aside designation, is performed at AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania. The award represents a child contract under the company's broader procurement relationship with the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $10,447.93 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. The work will be performed at the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,614.22 delivery order to AmerisourceBergen Drug Corp for QUVIVIQ 50 mg tablets (30-count supply) on September 19, 2025, with completion targeted for September 22, 2025. This firm fixed-price delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract carries no set-aside designation and was competitively...